These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2599082)

  • 21. [The influence of repirinast, an anti-allergic drug, on theophylline pharmacokinetics in patients with bronchial asthma].
    Nagata M; Tabe K; Houya I; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Apr; 29(4):413-9. PubMed ID: 1650860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical efficacy and characteristics of the effect of prolonged-action theophyllines on the external respiratory function and hemodynamics of bronchial asthma patients].
    Kakhnovskiĭ IM; Solomatin AS; Vdovina TI
    Ter Arkh; 1995; 67(1):48-51. PubMed ID: 7709358
    [No Abstract]   [Full Text] [Related]  

  • 23. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG
    Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of ranitidine on theophylline pharmacokinetics in patients with obstructive lung disease].
    Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V
    Plucne Bolesti; 1991; 43(1-2):89-93. PubMed ID: 1766997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced theophylline metabolism in patients with bronchial asthma at age 4 and under.
    Kizu J; Arakawa M; Arakawa Y; Komoda F; Takamizawa M; Iwata T; Hayakawa T; Imai K
    Biomed Chromatogr; 1999 Nov; 13(7):462-4. PubMed ID: 10534757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methylxanthine preparations in the therapy of bronchial asthma].
    Fedoseev GB; Kriakunov KN; Leĭchenko LV; Evartau EE
    Ter Arkh; 1987; 59(7):131-5. PubMed ID: 3313783
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
    Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
    Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
    Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship of the theophylline concentration in the saliva and the blood serum in patients with a broncho-obstructive syndrome].
    Tsoĭ AN; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1994; 66(8):42-4. PubMed ID: 7985153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of once-daily low-dose administration of sustained-release theophylline on airway inflammation and airway hyperresponsiveness in patients with asthma].
    Terao I
    Arerugi; 2002 Apr; 51(4):364-70. PubMed ID: 12014027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma].
    Inafuku M; Suzuki T; Ohtsu F; Hariya Y; Nagasawa K; Yoshioka Y; Nakahara Y; Hayakawa H
    J Cardiol; 1992; 22(1):227-33. PubMed ID: 1284909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Theopek absorption efficiency in chronic diseases of the large intestine].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Volchenok VI
    Eksp Klin Farmakol; 1993; 56(4):46-7. PubMed ID: 8220017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
    Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
    Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG; Moguel A
    Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.